SignalCorporate
BioHarvest Sciences GAAP EPS of -$0.15 misses by $0.01, revenue of $7.9M misses by $1.41M
GAAP EPS missed by $0.01 and revenue missed by $1.41M.
Context
What happened: BioHarvest Sciences (BHST) reported Q3 GAAP EPS of -$0.15, missing by $0.01, and revenue of $7.9M, missing by $1.41M.
Key numbers: Q3 GAAP EPS -$0.15 vs estimate miss of $0.01. Revenue $7.9M vs miss of $1.41M. FY2026 guidance: revenue $32M-$33.5M vs consensus $37.42M; adjusted EBITDA loss $5.5M-$7.5M. VINIA D2C guidance $31M-$32M; CDMO $1M-$1.5M.
Why it matters: FY2026 revenue guidance of $32M-$33.5M came in below the $37.42M consensus, and gross margin declined to 54% from 61% while operating and adjusted EBITDA losses widened year over year.
Coverage: 3 outlets in 24h
What changed
BioHarvest Sciences (BHST) reported Q3 GAAP EPS of -$0.15, missing by $0.01, and revenue of $7.9M, missing by $1.41M.
Why it matters
FY2026 revenue guidance of $32M-$33.5M came in below the $37.42M consensus, and gross margin declined to 54% from 61% while operating and adjusted EBITDA losses widened year over year.